Big Biotech Shares Take a Wild Ride
As the post-pandemic pharma landscape takes shape, Moderna and BioNTech slide, Pfizer rallies.
As the post-pandemic pharma landscape takes shape, Moderna and BioNTech slide, Pfizer rallies.
In recent days, shares of some of the biggest biotechnology and pharmaceutical stocks have seen wide swings, in part as investors reassess the competitive landscape for the post-coronavirus-pandemic world.
Shares of Moderna (MRNA) and BioNTech (BNTX)--both makers of COVID-19 vaccines--plummeted on Nov. 5 after Moderna reported disappointing third-quarter revenue and the company reduced 2021 sales forecasts. That same day, Moderna lost 16.6%. BioNTech--which reports earnings Tuesday morning--lost 20%. In contrast, Pfizer PFE rallied 11% on Nov. 5 after releasing impressive clinical results for an oral COVID-19 treatment.
Jakir Hossain does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.